Provenance du réseau au premier degré de Martijn Bax
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
AstraZeneca BV
1
| Subsidiary | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Martijn Bax via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Corporate Officer/Principal | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Vrije Universiteit Amsterdam | College/University | Doctorate Degree |
Statistiques
Internationale
| Pays-Bas | 4 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Marc Ditmarsch | 4 |
- Bourse
- Insiders
- Martijn Bax
- Connexions Sociétés
